This is a routine filing of updated articles of association with no new financial data. Monitor future 6-K filings for earnings releases or material corporate developments.
GMAB drugs
GMAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $51.74entry
- T+1 · 4d ago −0.72%α −0.35% · $51.37
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Genmab filed its updated Articles of Association on Form 6-K, reflecting routine governance updates including authorized capital increases for employee warrants and convertible debt instruments. No financial results, guidance, or material operational events were disclosed in this filing.
Key Facts
- Filed updated Articles of Association dated November 10, 2026
- Share capital is DKK 62,570,683 divided into shares of DKK 1 each
- Board authorized until March 12, 2029 to increase share capital by up to DKK 6,600,000 without pre-emption rights
- Board authorized until March 12, 2029 to issue convertible debt instruments up to DKK 3,000,000 nominal
- Multiple warrant programs for employees described, with authorizations extending to March 2030
- No financial results, earnings, or operational updates included
Financial Impact
No financial impact; routine governance filing
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000154 |
| Document: gmab_20261112x6kx2.htm | 0001434265-26-000154 |
| Document: 0001434265-26-000154-index-headers.html | 0001434265-26-000154 |
| Document: 0001434265-26-000154-index.html | 0001434265-26-000154 |
| Document: 0001434265-26-000154.txt | 0001434265-26-000154 |
| Earnings Context (Synthetic; results releases only) | 0001434265-26-000154 |
Track record
31 reports on GMAB
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Viewing Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $53.87 Now $51.57 −4.27% settles Dec 10
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
- Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers